As part of their therapy development, TMC launched a vast immunotherapy program for which they needed first-class, bug-free controls. The contract was awarded to LCS as integrator and Saia®PCD for the control system.
LCS has an excellent track record in innovative and special solutions for hospitals. Working with Saia®PCD and its standard, on-board web and
IT technologies, LCS was able to propose a high-tech solution at very affordable costs.
Since Saia®PCD integrates PLC functions with such IT features as a web server, ftp server, SD flash and open communication, there was guaranteed operational safety and simplicity for both
process and data.
In addition, the combination of robust PLC functions and advanced IT functions simplified the architecture and the integration. This optimum solution is now fully operational, and is running to the satisfaction of hospital researchers, maintenance crews and management.
Cancer and immunotherapy
Because cancer is an internal cell, it is not registered by the immune system as an intruder, so the body won’t fight it.
Cancer immunotherapy is the use of the immune system to reject cancer. By growing cancer cells in the laboratory and assimilating a coded antigen into them, the body will recognize and fight them. With some luck, the immune system will continue to destroy all similar tumours.